TOP TIERMARKET NEWSWIRE

News & sentiment

PHARMING GROUP N V ADR (PHAR) — News & AI sentiment

PHARMING GROUP N V ADR (PHAR) news roundup. 6 stories in the past week, 7 over 30 days. Average 30-day sentiment is 64.9/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

6

avg sentiment 63.5/100

30d stories

7

avg sentiment 64.9/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

PHAR news in the last 24 hours, 7 days, 30 days and 90 days

How much PHAR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	PHAR stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	6	63.5/100	PHAR headlines →
Last 30 days	7	64.9/100	PHAR headlines →
Last 90 days	23	53.4/100	PHAR headlines →

Latest stories on PHAR

Pharming wins FDA nod to extend Joenja use to younger APDS children

TipRanks73 · bullishproduct/pr

2d ago

FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

StockTitan73 · bullishproduct/pr

2d ago

Pharming wins approval of Joenja for younger age group

Seeking Alpha73 · bullishproduct/pr

2d ago

Pharming: Faltering Rare-Disease Franchise With Two Potentially Transformative Late-Stage Assets

Seeking Alpha52 · neutralgeneral

4d ago

Pharming Group to participate in September investor conferences

GlobeNewswire55 · neutralgeneral

4d ago

Pharming Group to participate in September investor conferences

StockTitan55 · neutralgeneral

4d ago

PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results

Business Insider73 · bullishearnings

Aug 20

Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

Business Insider73 · bullishproduct/pr

Aug 13

Pharos shares drop as Serica declines to raise bid; Ratio tables higher offer

Investing.com Markets34 · bearishm&a

Aug 10

Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky

PR Newswire34 · bearishgeneral

Aug 7

Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference

StockTitan55 · neutralgeneral

Aug 4

Pharming (PHAR) Q2 2026 Earnings Call Transcript

The Motley Fool63 · neutralearnings

Aug 3

PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group

PR Newswire34 · bearishgeneral

Aug 3

Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR)

PR Newswire32 · bearishgeneral

Jul 31

Pharming (PHAR) Q2 2026 Earnings Call Transcript

The Motley Fool63 · neutralearnings

Jul 31

Oppenheimer cuts Pharming Group stock price target on lowered guidance

Investing.com Analyst Ratings38 · neutralanalyst

Jul 30

Pharming Group N.V. (PHAR) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Jul 30

Pharming Group Q2 Earnings Call Highlights

Yahoo Finance38 · neutralearnings

Jul 30

Pharming Group N.V. 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Jul 30

Pharming GAAP EPS of $0.00 misses by $0.06, revenue of $90.2M misses by $9.32M

Seeking Alpha34 · bearishearnings

Jul 30

Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

Business Insider56 · neutralearnings

Jul 30

Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30 | PHARM Stock News

StockTitan50 · neutralgeneral

Jul 16

Pharma Mar Launches €8 Million Share Buyback for Potential Corporate Deals

TipRanks71 · bullishgeneral

Jul 1

Pharming Wins FDA Review for Joenja Pediatric sNDA in APDS

TipRanks73 · bullishproduct/pr

Jun 4

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS | PHARM Stock News

StockTitan73 · bullishproduct/pr

Jun 4

Open PHAR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →